Working in silos, change will not occur. WBC convenes with our Partners, Champions, and Sponsors to move faster together toward our action initiative goals.
Join us for Our Annual Action for Impact Summit!
WBC’s Annual Action for Impact Summit unites thousands of attendees on a fully interactive platform, enabling participants to network, connect, and exchange ideas, innovations, and impact in real time.
WOMEN CEO REPORT
Rachel McMinn, Ph.D., is the CEO of Neurogene Inc., a biopharmaceutical company focused on developing innovative gene therapies for neurological disorders. Dr. McMinns leadership is marked by her dedication to advancing gene therapy and addressing unmet medical needs in neurology. With extensive experience in biotechnology and genetic research, she has been instrumental in guiding Neurogene through critical stages of research and clinical development. Her strategic vision includes harnessing advanced gene-editing technologies to develop transformative treatments and improve patient outcomes. Under her leadership, Neurogene continues to progress in its mission to provide innovative solutions for complex neurological conditions.
